Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 3.88
- Piotroski Score 9.00
- Grade Outperform
- Symbol (HOLX)
- Company Hologic, Inc.
- Price $78.02
- Changes Percentage (-0.7%)
- Change -$0.55
- Day Low $77.60
- Day High $78.49
- Year High $84.67
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 01/30/2025
- Fiscal Year End N/A
- Average Stock Price Target $82.50
- High Stock Price Target $95.00
- Low Stock Price Target $33.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $1.94
- Trailing P/E Ratio 38.41
- Forward P/E Ratio 38.41
- P/E Growth 38.41
- Net Income $789.50 M
Income Statement
Quarterly
Annual
Latest News of HOLX
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Hologic, Inc.'s (NASDAQ:HOLX) Intrinsic Value Is Potentially 92% Above Its Share Price
The intrinsic value estimate for Hologic, Inc. is 77% higher than the analyst price target. Using a Discounted Cash Flow model, the calculated present value is US$36b, showing the stock is undervalued...
By Yahoo! Finance | 2 months ago -
Hologic's (NASDAQ:HOLX) Earnings Seem To Be Promising
Shareholders were pleased with Hologic, Inc.'s strong earnings report. Despite unusual expenses affecting profits, analysts predict an increase in future profitability. Considering various factors bey...
By Yahoo! Finance | 3 months ago -
Hologic, Inc. (HOLX) Stock Forecasts
David H. Toung is a Senior Analyst at Argus, specializing in Medical Devices & Healthcare Services. With over 20 years of experience in financial analysis, he has worked for top firms like JPMorgan Ch...
By Yahoo! Finance | 3 months ago
